• Evaluación Económica del uso de La Gasa Sintética Frente a la Gasa de Algodón de Pieza Única En El Manejo de Heridas en Colombia

    Nov 1, 2015, 00:00

  • External Reference Pricing from the Perspective of Slovenia

    Nov 1, 2015, 00:00

  • Diabetes In Turkey- Analysis of Patient Characteristics

    Nov 1, 2015, 00:00

  • Humanistic and Economic Burden of Focal Drug-Refractory Epilepsy In Europe

    Nov 1, 2015, 00:00

  • Competition And Strategic Regulation In The Argentine Pharmaceutical Market- A Comparative Study Of Six Therapeutic Classes

    Nov 1, 2015, 00:00

  • Organizational Models of Hospital Based HTA- Empirical Evidence from Adhophta European Project

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Cardioprotective Effect of Dexrazoxane (Cardioxane®) in Advanced/Metastatic Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy in México

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Secukinumab Compared to Ustekinumab In The Treatment of Moderate to Severe Plaque Psoriasis In The Czech Republic

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of The Fixed Combination Indacaterol/Glycopyrronium Vs. Tiotropium And Salmeterol/ Fluticasone In The Management Of Copd In Greece

    Nov 1, 2015, 00:00

  • Economic Study Design for the Optimize Study on Orbital Atherectomy and Drug-Coated Balloon Devices for the Treatment of Below-The-Knee Peripheral Arterial Disease

    Nov 1, 2015, 00:00

  • Assessment of Tofacitinib For Rheumatoid Arthritis From The Perspective of The Brazilian Healthcare System

    Nov 1, 2015, 00:00

  • Hexaminolevulinate Blue-Light Flexible Cystoscopy In Addition To Standard White-Light Cystoscopy In The Follow-Up Of Non-Muscle Invasive Bladder Cancer- Cost-Consequences During Outpatient Surveillance In Sweden

    Nov 1, 2015, 00:00

  • Modelling Health Benefits Associated to Early Diagnosis and Treatment of Copd

    Nov 1, 2015, 00:00

  • Health Care Resource Utilization and Direct Medical Costs Among Patients With Epilepsy In Tianjin, China

    Nov 1, 2015, 00:00

  • The Association Between Smoking Cessation Outpatient Visits And Total Medical Costs- An Analysis Of Japanese Employee Based Public Health Insurance Data

    Nov 1, 2015, 00:00

  • Inconsistency in the Valuations of Euroqol Eq-5d-5l Health States in China was More Related to Interviewer and to Interview Process than to Respondents’ Characteristics

    Nov 1, 2015, 00:00

  • Analysis of the Reports of the National Committee for Technology Incorporation (Conitec) in the Brazilian Public Health System (Sus), 2012-2015

    Nov 1, 2015, 00:00

  • Identification of Osteoporosis Chronic Inflammatory Rheumatic Disease In French Claims Data

    Nov 1, 2015, 00:00

  • Disease Burden, Outcomes and Costs Among Adults Admitted To Hospital In The United Kingdom (Uk) Due to Plaque Or Erythrodermic Psoriasis

    Nov 1, 2015, 00:00

  • Consumo De Benzodiazepinas En La Poblacion Geriatrica Atendida En El Hospital Clinico Regional De Concepcion

    Nov 1, 2015, 00:00

  • Biologic treatments for moderate-severe psoriasis. What efficacy gives you, cost should not take it away

    Nov 1, 2015, 00:00

  • Using Machine Learning To Populate A Markov Model By Mining Big Data Directly From Hospital Ehrs – An Application To Dynamically Predict Hospital-Acquired Pressure Ulcers

    Nov 1, 2015, 00:00

  • Validation of a Short “Occupational Disability Index” As a Measure for Disease Impacts on Work Performance and Occupational Handicaps

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Quadrivalent Human Papilloma Virus (Hpv6/11/16/18) Vaccination In Ecuador

    Nov 1, 2015, 00:00

  • The Cost Effectiveness Of Idelalisib In Chronic Lymphocytic Leukaemia In England And Wales

    Nov 1, 2015, 00:00

  • A Systematic Literature Review of Economic Burden of Myelofibrosis

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% for Actinic Keratosis Treatment In Spain

    Nov 1, 2015, 00:00

  • Quantifying the Impact of Health-Related Quality of life (Hrql) on Medical Expenditures in Asthma, arthritis, Depression, Diabetes, and Migraine

    Nov 1, 2015, 00:00

  • Introduction Of An Organizational Model Of Telemedicine In Management Of Oral Anticoagulant Therapy- A Budget Impact Analysis From Italian Payer Perspective

    Nov 1, 2015, 00:00

  • Do Not Overlook Your Country-Specific Characteristics- The Case Of Baroreflex Activation Therapy (Bat) For The Treatment Of Resistant Hypertension

    Nov 1, 2015, 00:00

  • A Cross-Sectional Epidemiological Cancer Registry In Egypt

    Nov 1, 2015, 00:00

  • Estimating The Burden Of Diabetes To The French National Health Insurance

    Nov 1, 2015, 00:00

  • Understanding Local Commissioning Decisions on New Pharmacotherapies In The Uk

    Nov 1, 2015, 00:00

  • Economics of Diabetes Mellitus- Theory And Evidence For Brazilian Data In 2008

    Nov 1, 2015, 00:00

  • Costo En Salud De La Intervenci”N En La Atenci”N Del Parto Normal En El Peru 2009 Y 2014

    Nov 1, 2015, 00:00

  • Assessing The Rationality of Costs of Drug Treatment of Nonalcoholic Steatohepatitis In The Hospital of Ukraine

    Nov 1, 2015, 00:00

  • Costos económicos de la otitis media aguda. Una revisión de la literatura

    Nov 1, 2015, 00:00

  • Importance of Hypoglycemia Barrier on The Treatment of Diabetes Mellitus (Dm) – Survey With Turkish Physicians

    Nov 1, 2015, 00:00

  • Wintertime Surgery Increases The Risk of Osteonecrosis After Internal Fixation of Femoral Neck Fracture

    Nov 1, 2015, 00:00

  • Scoring and Measurement Properties of a Tool to Assess Primary Care Physicians’ Engagement in and Perceived Barriers to Vaccination- the ‘Determinant of Intentions of Vaccination’ (Diva©) Questionnaire

    Nov 1, 2015, 00:00

  • A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in Treatment and Secondary Prevention of Venous Thromboembolism (Vte) in Patients with Deep Vein Thrombosis (Dvt)

    Nov 1, 2015, 00:00

  • Data Framework To Improve Relationship In Drugs Therapies Between Gps And Hospital Physicians

    Nov 1, 2015, 00:00

  • Tailoring Sponsor-Payer Engagement to Facilitate Effective and Fair Patient Access

    Nov 1, 2015, 00:00

  • Transthyretin Familial Amyloid Polyneuropathy Impact on Health-Related Quality of Life

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Guideline for Positive Drug List Application Purposes Implemented In Bulgaria

    Nov 1, 2015, 00:00

  • Comparing Cost-Effectiveness Of Emerging Drugs In Advanced Cancer Without Hazard Ratios For Progression

    Nov 1, 2015, 00:00

  • Priority issues and Recommendation Selection in Cancer Pain Management

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Certolizumab Pegol for The Treatment of Active Psoriatic Arthritis In Greece

    Nov 1, 2015, 00:00

  • Cardiovascular Event Rates in a High-Risk General Population Cohort of 340,000 Individuals in the United Kingdom

    Nov 1, 2015, 00:00

  • Extended-Release Oxycodone Hydrochloride (Oxycontin®) for Pain Management In Patients Undergoing Arthroplasty- A Cost Analysis From The Brazilian Public and Private Healthcare Systems Perspectives

    Nov 1, 2015, 00:00

  • Characteristics of Acne Vulgaris In European Adolescents And Patients Perceptions

    Nov 1, 2015, 00:00

  • Validation of Social Media Analysis for Outcomes Research- Identification of Drivers of Switches between oral and Injectable Therapies for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-on Therapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

    Nov 1, 2015, 00:00

  • Knowledge On The Appropriate Technique Of Bloos Pressure Monitoring And Limits Of The Oscillometric Blood Pressure Measurement

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Sitagliptin Compared to Sulphonylurea as an Add-on to Metformin in the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2015, 00:00

  • Prescribing Patterns for upper Respiratory Tract Infections- A Prescription-Review of Primary Care Practice in Kota Setar District, Kedah, Malaysia

    Nov 1, 2015, 00:00

  • Disease Mapping And Spatial-Temporal Analysis Of Hospital Admissions Due To Heart Failure In Portugal

    Nov 1, 2015, 00:00

  • Brazilian Guideline for Academic Detailing- a Need to Improve Health Care

    Nov 1, 2015, 00:00

  • A Systematic Review of The Impact of Improved Housing Interventions on Health In Low And Middle Income Tropical Settings

    Nov 1, 2015, 00:00

  • A Systematic Literature Review of The Economic Implications of Acute Bacterial Skin And Skin Structure Infections (Absssis)

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of The Use of Voriconazole, Posaconazole And Micafungin In The Primary Prophylaxis of Invasive Fungal Infections In Recipients of Allogeneic Hematopoietic Stem Cell Transplants In Spain

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ikervis® In Severe Dry Eye Disease In The Uk [Update]

    Nov 1, 2015, 00:00

  • Endovascular Interventions For Treatment Of Femoropopliteal Peripheral Artery Disease- Updated Budget Impact Analysis For Germany Based On Latest Clincal Evidence

    Nov 1, 2015, 00:00

  • Economic Burden In Direct Costs Of Obesity And Overweight In Russia

    Nov 1, 2015, 00:00

  • Use Pattern Narcotic Analgesics For Cancer Patient In South Korea - Claims Data Analysis

    Nov 1, 2015, 00:00

  • Rivaroxavan+Enoxiparina Comparado A Enoxiparina En Pacientes Postoperador De Remplazo Articular De Rodilla Y Cadera

    Nov 1, 2015, 00:00

  • Increased Risk of Osteoporosis In Depressed Patients- A Real World Data Study Conducted In Italy

    Nov 1, 2015, 00:00

  • Fast-Tracking Innovation- A Scorecard for The Fda’s Expedited Review Process

    Nov 1, 2015, 00:00

  • Measurement Invariance of the Whoqol-Old Module Across Different Demographic Groups in Taiwan’s Elderly People

    Nov 1, 2015, 00:00

  • Mapping the Diagnostic Pathway for Breast Cancer in England and Comparison to Europe

    Nov 1, 2015, 00:00

  • Evaluation Of Resource Utilizaton For Chemotherapy Induced Nausea And Vomiting (Cinv) In Patients Treated With Anthracycline+Cyclophosphamide (Ac) For Solid Cancers With And Without Nk-1 Based Regimens

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of High-Risk Hpv Dna (Hrhpv) Test With 16/18 Genotyping As A Primary Screening Method For Cervical Cancer In Greece

    Nov 1, 2015, 00:00

  • An Economic Analysis of Informal Care Provision in Ireland

    Nov 1, 2015, 00:00

  • Persistence and Econ”Mic Impact of Etanercept and Adalimumab Dose Reduction In Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Patients With At Least 1 Year In Clinical Remission- Experience From 2 Spanish Teaching Ho ...

    Nov 1, 2015, 00:00

  • Investigating The Accessibility Of Uninsured Population To Health Services In Greece

    Nov 1, 2015, 00:00

  • Reimbursed Price of Orphan Drugs- A Value Based Framework

    Nov 1, 2015, 00:00

  • Governance, Decision-Making, and Universal Health Coverage- perceptions from Chilean Health Decision-Makers

    Nov 1, 2015, 00:00

  • Hospital Cost Analysis Of Patients With Cardiovascular Events And Revascularisation Procedures In Spain

    Nov 1, 2015, 00:00

  • Medical Cost Of Patients With Non-Valvular Atrial Fibrillation (Nvaf) And Treated With Vitamin K Antagonists (Vkas) According To Inr Control Status In Spain

    Nov 1, 2015, 00:00

  • Does A Shorter Protocol Time for Chest Pain Patients Impact Emergency Department Flow? A Queuing Model to Discuss Emergency Department Management Metrics

    Nov 1, 2015, 00:00

  • Pro Claims in Fibromyalgia- A Review of the Labels of Products Approved by the Fda and the Ema

    Nov 1, 2015, 00:00

  • Comparison of a Profile and Multi-Profile Best Worst Scaling Task- a Preference Study in Parkinson’s Patients

    Nov 1, 2015, 00:00

  • Health Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine In Finnish Home Care Customers ≥50 Years With Underlying Chronic Medical Conditions

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson`S Disease

    Nov 1, 2015, 00:00

  • Stochastic Multicriteria Acceptability Analysis In A Bayesian Framework

    Nov 1, 2015, 00:00

  • Consulta Aos Membros De Agências Internacionais De Ats Como Estratégia De Intercâmbio Do Conhecimento Produzido – O Caso Do Pet-Tc

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Canacinumab In The Treatment of Patients With Muckle–Wells Syndrome In The Russian Federation

    Nov 1, 2015, 00:00

  • Anthropometric Study on Mongolians with Metabolic Syndrome

    Nov 1, 2015, 00:00

  • Understanding The Underutilisation Of Evidence From Economic Evaluations In Healthcare- A Mixed Methods Design

    Nov 1, 2015, 00:00

  • Inappropriate Drug Prescription- Still on-Going Among Malaysian Older Adults

    Nov 1, 2015, 00:00

  • Adjusting For Cross-Over In Oncology Trials- Approaches Taken To Support Drug Reimbursement In Australia

    Nov 1, 2015, 00:00

  • Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study

    Nov 1, 2015, 00:00

  • Diagnoses And Treatment Patterns For Non-Small Cell Lung Cancer (Nsclc) Within The Private Health System In Brazil

    Nov 1, 2015, 00:00

  • Tiered Pricing in Oncology - Drivers for Improved Patient Access and Commercial Success

    Nov 1, 2015, 00:00

  • Estimaci”N de Costos Directos Asociados al Cambio de Terapia iv A oral en Infecci”N Complicada de Piel y Tejidos Blandos en Chile

    Nov 1, 2015, 00:00

  • Burden of Disease in Patients with Glaucoma in Brazil-

    Nov 1, 2015, 00:00

  • Eastern Cooperative Oncology Group (Ecog) Performance Status (Ps) Is An Independent Predictor Of Hrqol In Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Cost-Effective Evaluation of Pirfenidone for Treating Idiopathic Pulmonary Fibrosis in Mexico

    Nov 1, 2015, 00:00

  • A Validity and Reliability Study of the Poverty Related Quality of Life Questionnaire in a Turkish Patient Population

    Nov 1, 2015, 00:00

  • Resource Use And Health Care Costs Of Copd Patients At The End Of Life- A Systematic Review

    Nov 1, 2015, 00:00

  • Measuring Generic Health-Related Quality Of Life And Impact Of Health Resource Utilization In Adults With Cystic Fibrosis

    Nov 1, 2015, 00:00

  • Medical Resource Utilisation of Australian Patients With Genotype 1 Chronic Hepatitis C- A Retrospective Observational Study

    Nov 1, 2015, 00:00

  • The Impact Of New Endovascular Therapies For Femoropopliteal Arterial Disease On Therapy Utilization And Case Volumes In Germany, 2009-2013

    Nov 1, 2015, 00:00

  • Review of Patient Reported Outcome Measures used in Clinical and Cost-Effectiveness Studies to Measure Utilities in the Treatment of Psoriatic Arthritis and Ankylosing Spondylitis

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Urothelial Transitional Cell Cancer Treatment with Vinflunine in Patients Resistant to the Platinum-Based Treatment Regimes

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Considerations About Breakthrough Cancer Pain

    Nov 1, 2015, 00:00

  • The Cumulative Analysis of Checklist Questionnaires Filled Out by the Hungarian HTA Office

    Nov 1, 2015, 00:00

  • Impact Of Cancer Diagnosis And Treatment On Glycaemic Control Among Individuals With Colorectal Cancer Using Glucose Lowering Drugs

    Nov 1, 2015, 00:00

  • Costs of Mental Disorders in Poland and Their Complications

    Nov 1, 2015, 00:00

  • Impact of Assessments of New Medicines By The Smc In England

    Nov 1, 2015, 00:00

  • Using An Economic Model To Choose Initial Appropriate Antibiotic Therapy Based On Differences In In-Vitro Susceptibility To Ceftolozane/Tazobactam And Piperacillin/Tazobactam

    Nov 1, 2015, 00:00

  • Evaluacion De Costo-Efectividad De Un Programa De Cuidados Integrales Post-Alta Tipo Hospital De Dia Para Adultos Mayores Comparado Con El Manejo Estandar En El Sistema Publico

    Nov 1, 2015, 00:00

  • Review of Economic Models for The Evaluation of Biologic Dmards In Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Assessment of Validation of Health-Economics Decision Models In Intervention Studies of Seasonal Influenza and Breast Cancer

    Nov 1, 2015, 00:00

  • Transitioning From Generic To Protected Brand Drug In Patients With Dm, Hypertension And Hyperlipidemia

    Nov 1, 2015, 00:00

  • Primary Non-Adherence to Antiosteoporotic Treatment and Associated Factors- A Prospective Cohort Study in Spain

    Nov 1, 2015, 00:00

  • Potential Barriers to Insulin Intensification Among Patients With Type 2 Diabetes- The Patient Perspective In Germany

    Nov 1, 2015, 00:00

  • Dapagliflozin Versus a Dipeptidyl Peptidase 4 Inhibitor (DPP4) Both Added to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM)- Impact on Health, Quality of Life and Costs in the Turkish Clinical Setting

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Obinutuzumab For Previously Untreated Chronic Lymphocytic Leukemia (Cll) In Portuguese Patients That Are Unsuitable For Full-Dose Fludarabine Based Therapy

    Nov 1, 2015, 00:00

  • The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses

    Nov 1, 2015, 00:00

  • Impact On Italian National Health Service Expenditure For The Treatment Of Venous Thromboembolism With Rivaroxaban

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis To Assess The Comparative Efficacy And Safety Of Treatments For Chronic Obstructive Pulmonary Disease

    Nov 1, 2015, 00:00

  • Role of Puppet Plays In Improving Children’s Knowledge About Hand Washing and Using Normal Saline to Rinse Nose and Throat

    Nov 1, 2015, 00:00

  • Statins Use And The Risk Of Hematological And Non-Hematological Malignancies- A Meta-Analysis Of 53 Observational Studies

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Apremilast In Patients With Psoriatic Arthritis In The Italian Setting

    Nov 1, 2015, 00:00

  • The Burden of Adult Pneumococcal Disease in 50+ Population in Hungary

    Nov 1, 2015, 00:00

  • Angiotensin Converting Enzyme Inhibitors Prescribing Pattern For Different Indications- A Population Based Study

    Nov 1, 2015, 00:00

  • Eight Ways to Improve The Interpretation and Reporting of Cost-Effectiveness Analyses of Screening Interventions

    Nov 1, 2015, 00:00

  • Cost Analysis Study of Oral Anti-Diabetic Drugs Available in Indian Govt Generic (Jan Aushadhi,Jeevandhara ) Drugs and Brand Drugs Market in Rural / Urban Area of Guntur, Andhrapradesh, India

    Nov 1, 2015, 00:00

  • Access to Biological Therapies and Consumption Trends in Bosnia and Herzegovina

    Nov 1, 2015, 00:00

  • Burden of Cost in Chronic Graft Versus Host Disease Following Hematopoietic Stem Cell Transplantation- Predictions for the Next Decade

    Nov 1, 2015, 00:00

  • Exploring Before And After Risk-Sharing Scheme Implementation During 8.5 Years Focused On Anticancer Drugs

    Nov 1, 2015, 00:00

  • Capturing Emotional Concepts During Concept Elicitation

    Nov 1, 2015, 00:00

  • Development of a Preference-Based Instrument- Compared with Eq-5d

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Botulinum Toxin Type a Treatment for Cerebral Palsy

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Various Treatment Strategies For Patients With Chronic Venous Insufficiency Of The Lower Limbs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Escalating to Natalizumab or Switching Among Immunomodulators In Relapsing-Remitting Multiple Sclerosis In Italy

    Nov 1, 2015, 00:00

  • Design And Evaluation of Transdermal Patch of Felodipine

    Nov 1, 2015, 00:00

  • Idntification of Chromosomal Alteration and Association Study of Mthfr Gene Mutations In Autism

    Nov 1, 2015, 00:00

  • Development of A Conceptual Model of Multiple Myeloma for Use In Economic Modelling- A Systematic Literature Review to Identify The Evidence Base

    Nov 1, 2015, 00:00

  • Broad Access to Treatment is Cost-Effective for Patients with Chronic Hepatitis C in England

    Nov 1, 2015, 00:00

  • Evaluación Costo-Efectividad Del Uso Del Régimen Combinado De Mifepristona Y Misoprostol Para Aborto Incompleto O Diferido En Mujeres Con Embarazos De Hasta 12 Semanas De Gestación En Instituciones De Salud Pública En México

    Nov 1, 2015, 00:00

  • Appropriateness Score and Cost Evaluation In Hiv- The Aprosce System, on Field Clinical Evaluation

    Nov 1, 2015, 00:00

  • The Evolution of HTA as a Coverage Decision-Making Tool in the Middle East and North Africa Region

    Nov 1, 2015, 00:00

  • Rheumatoid Arthritis and Ischemic Heart Disease In Patients From Blumenau - Brazil

    Nov 1, 2015, 00:00

  • Heart Failure in a Health Area of Madrid, Spain. Description and Management from Electronic Medical Records

    Nov 1, 2015, 00:00

  • Reporting Instruments of Patient Reported Outcomes In Orphan Disease

    Nov 1, 2015, 00:00

  • Assessing Retrospective Data on the Management of Ischemic Stroke

    Nov 1, 2015, 00:00

  • Establshing The Cost-Effectiveness of Genomic-Based Diagnostic Tests- Are Current Methods Sufficient and Appropriate?

    Nov 1, 2015, 00:00

  • Chemotherapy Exposure and outcomes Among Patients Diagnosed with Chronic Lymphoid Leukemia

    Nov 1, 2015, 00:00

  • The Link Between Proton Pump Inhibitors and Ischemic Heart Disease Could be Explained by Protopathic Bias- a Pharmacovigilance Analysis

    Nov 1, 2015, 00:00

  • Early Health Economic Assessment in Innovation Partnerships- Lessons from the European Innovation Partnership on Active and Healthy Ageing

    Nov 1, 2015, 00:00

  • Retos Metodol”Gicos de Las Políticas de Fijaci”N de Precios de Referencia Para Grupos de Medicamentos de Utilidad Terapéutica Similar

    Nov 1, 2015, 00:00

  • A Comparison Of Fat Grafting Methods On Operating Room Efficiency And Cost

    Nov 1, 2015, 00:00

  • Translation and Validation of The Polish Diabetic Foot Ulcer Scale - Short Form (Dfs-Sf)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

    Nov 1, 2015, 00:00

  • Simulated Treatment Comparison of Time-To-Event (And Other Non-Linear) Outcomes

    Nov 1, 2015, 00:00

  • Knowledge And Contraceptive Use Among Currently Married Women Aged 15-49 In Western Kenya

    Nov 1, 2015, 00:00

  • Economics Analysis of Dapagliflozin Compare to Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus in Spain- Cost of Achieving Composite Endpoints

    Nov 1, 2015, 00:00

  • Appraising The Cost Of Physician Visits And Technical Procedures In France In The Age Of Open Data

    Nov 1, 2015, 00:00

  • Implementing the Full Economic Evaluations of Medicines in the HTA Programmes in Catalonia- First Steps and Future Perspectives

    Nov 1, 2015, 00:00

  • Apresentação do Programa Desfechos de um Hospital Privado de São Paulo, Brasil

    Nov 1, 2015, 00:00

  • Modeling Treatment Sequences In Health Technology Assessments

    Nov 1, 2015, 00:00

  • Health Economic Evaluation of Different Vaccination Strategies Against Varicella and Herpes Zoster in Germany

    Nov 1, 2015, 00:00

  • Effect Of Intervention By Community Pharmacists On Awareness Of Continuing Treatment Among Patients With Hypertension

    Nov 1, 2015, 00:00

  • Comparison of Timed Automata with Discrete Event Simulation for Modeling Personalized Treatment Decisions- the Case of Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Health Spending And Health Outcomes In The Management Of Hemodialysis For Two Insurance Companies In Colombia

    Nov 1, 2015, 00:00

  • Doctors’ Failure In Observance Of The Copd Management Guidelines- The Czech Republic 2015 Update

    Nov 1, 2015, 00:00

  • Vial Sizes Of Pharmaceuticals For Infusion – The Potential For Cost Reductions And Reduced Wastage By Optimising Fill Volumes

    Nov 1, 2015, 00:00

  • The Cost Effectiveness of Delayed-Release Dimethyl Fumarate Versus Interferon Beta-1b In A Swedish Setting

    Nov 1, 2015, 00:00

  • Validity and Responsiveness of Preference Based Measures- A Critical Overview of Reviews

    Nov 1, 2015, 00:00

  • Predictive Analysis of Factors Influencing Health Technology Assessment Recommendation- A Literature Review

    Nov 1, 2015, 00:00

  • Can We Improve The Inhalation Techniques In Patient With Copd?. Tiepoc Study

    Nov 1, 2015, 00:00

  • Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands

    Nov 1, 2015, 00:00

  • Selection Of Statistical Approach In Understanding The Role Of Contrast Media In Inpatient Interventional Cardiovascular Procedures

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Manual Therapy Versus Physical Therapy In Patients With Sub-Acute and Chronic Neck Pain- A Randomized Controlled Trial

    Nov 1, 2015, 00:00

  • Direct Cost of Myelodysplastic Syndromes Associated With A Deletion 5q Cytogenetic Abnormality (Del5q Mds) In Patients Who Are Red Blood Cell Transfusion Dependent In Mexico

    Nov 1, 2015, 00:00

  • Cognitive Testing of A Modified Version of The Faces Pain Scale-Revised In Children With Sickle-Cell Disease

    Nov 1, 2015, 00:00

  • Economic Analysis of Ustekinumab for Psoriatic Arthritis in Russia

    Nov 1, 2015, 00:00

  • The Impact of Consumer-Directed Health Plans on Price Shopping

    Nov 1, 2015, 00:00

  • Evaluación Económica De La Adición De Pertuzumab Al Tratamiento De Trastuzumab+Docetaxel En Pacientes Con Cáncer De Mama Her2 Positivo Metastásico Frente Al Tratamiento Con Trastuzumab+Docetaxel+Placebo, En El Contexto Venezolano

    Nov 1, 2015, 00:00

  • Efetividade Clínica Comparativa Do Análogo De Insulina Glargina Para Tratamento De Pacientes Acometidos Por Diabetes Mellitus Tipo 1

    Nov 1, 2015, 00:00

  • Engaging Patients with E-Clinical Technology- Incorporating Patient Preferences into Disease Management and Care

    Nov 1, 2015, 00:00

  • Trio H’s (Hyperglycemia, Hypertension, Hyperlipidemia)- Undiagnosed Modifiable Risk Factors In Malaysia Rural Community

    Nov 1, 2015, 00:00

  • Is Regenerative Medicine Cost-Effective? Evidences From The First Approved Stem Cell Based Product

    Nov 1, 2015, 00:00

  • The Cancer Drugs Fund and Patient Acces Schemes within the UK- Increased Access to Oncology Medicines or Reduced Value For Money?

    Nov 1, 2015, 00:00

  • The Impact of Spa Therapy on Ambulatory Health Care Expenses of osteoarthritic Patients- The Preliminary Results of Ecotherm Study

    Nov 1, 2015, 00:00

  • Liraglutide vs Other Daily GLP-1 Analogues in People with Type 2 Diabetes- A Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Cost–Utility Analysis of Antihemophilic Factor Rfviii-Fs for Secondary Prophylaxis Vs on-Demand Therapy In Severe Haemophilia A In Italy

    Nov 1, 2015, 00:00

  • The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of A Device to Monitor Levodopa-Induced Dyskinesia In Parkinson’s Patients

    Nov 1, 2015, 00:00

  • Evaluation Of A Payment By Results Scheme In A Catalan Cancer Center- Gefinitib In Egfr Mutation-Positive Advanced Non-Small Cell Lung Cancer

    Nov 1, 2015, 00:00

  • Desarrollo e Implementaci”n de un Modelo de Auditoría Médica Basado en Garantía de Calidad y Supervisi”n Participativa en Ecuador

    Nov 1, 2015, 00:00

  • Correcting for Switching to Second Line Treatment in the Survival Analysis- An Example of the Use of Inverse Probability of Censoring Weighted Analysis

    Nov 1, 2015, 00:00

  • The Safety And Tolerability Of The Fentanyl Iontophoretic Transdermal System Compared To Other Post-Operative Pain Modalities- A Systematic Review And Bayesian Network Meta-Analysis (Nma)

    Nov 1, 2015, 00:00

  • Cost Of Illness In Aortic Stenosis Patients

    Nov 1, 2015, 00:00

  • Multiple Pill Regimens, Single Tablet Regimens and Hiv+ Patients Quality of Life- Evidence from the Straq Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apremilast In Psoriatic Arthritis In Scotland

    Nov 1, 2015, 00:00

  • The Comparative Pharmacoeconomic Analysis of Using Korifollitropin Alfa with Ganirelix and Follitropin Alfa with Cetrorelix for Ovarian Stimulation

    Nov 1, 2015, 00:00

  • Haemodialysis Versus Non-Dialysis Therapy Among Older Adults With Stage 5 Chronic Kidney Disease- A Comparison of Health-Related Quality of Life

    Nov 1, 2015, 00:00

  • Health Status and Quality of Life Among Nurses

    Nov 1, 2015, 00:00

  • Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc ...

    Nov 1, 2015, 00:00

  • Evaluation of Patients’ Quality of Life of Preoperation and Early Postoperation After Total Hip and Knee Arthroplasty

    Nov 1, 2015, 00:00

  • Outcome of Harkány Thermal Water Completed Puva Therapy Versus Traditional Puva Therapy of Psoriatic Patients

    Nov 1, 2015, 00:00

  • Modeling The Impact of Potential Differences In Real-Wolrd Adherence With Extended-Half-Life Vs. Conventional Factor Viii And Ix on Bleeding

    Nov 1, 2015, 00:00

  • Proceso De Incorporación De Fármacos A La Lista Positiva De Medicamentos (Lpm) Para Los Prestadores Integrales De Salud- Experiencia En El Ministerio De Salud Pública (Msp) De Uruguay

    Nov 1, 2015, 00:00

  • The Feasibility of Applying Definitions of Persistent Opioid Utilisation to Quantify The Persistency of Tramadol Users

    Nov 1, 2015, 00:00

  • Decision-Analytic Modeling Studies- An Overview for Clinicians Using Dlbcl As An Example

    Nov 1, 2015, 00:00

  • Projected Clinical And Economic Impact Of Grazoprevir (Gzr, Mk-5172)/Elbasvir (Ebr, Mk-8742) For Chronic Hcv Genotype 1 Infection In Chronic Kidney Disease

    Nov 1, 2015, 00:00

  • Evaluación de Costo Efectividad de Dolutegravir (dtg) Vs Raltegravir (Ral) En Segunda Línea de Tratamiento en Pacientes Con Vih en Colombia

    Nov 1, 2015, 00:00

  • Budget Impact Analysis And Long-Term Disease Implications Of Hepatitis C Treatments In Sweden

    Nov 1, 2015, 00:00

  • Tools for Measuring Workability – Results Derived from Literature and Expert Interviews

    Nov 1, 2015, 00:00

  • Inequity in Access to Alzheimer Disease Indicated Treatment Across Different Geographic Areas of Turkey

    Nov 1, 2015, 00:00

  • Mortality Trends in Cardiovascular Disease- a New Model to Visualise the Contribution of Specific Diseases, Cohort Effects and Coding Changes to Overall Mortality Improvement

    Nov 1, 2015, 00:00

  • Age Related Consultation Rates of Clinically-Diagnosed Influenza And Acute Respiratory Illnesses Observed Through A Network of Gp Practices Across England

    Nov 1, 2015, 00:00

  • Development of A Cost-Effectiveness Analysis Framework for Modeling Treatment of Alzheimer’s Disease And Mild Cognitive Impairment

    Nov 1, 2015, 00:00

  • Evidence Review Group (ERG) Critique of Systematic Reviews (SR) Submitted to Nice as Part of Single Technology Appraisals (STA) or Multiple Technology Appraisals (MTA) in the Last Three Years

    Nov 1, 2015, 00:00

  • Real World Evidence in Oncology – Status Quo in Germany

    Nov 1, 2015, 00:00

  • Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29)- Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study

    Nov 1, 2015, 00:00

  • Partitioned Survival Versus State Transition Modeling in Oncology- a Case Study with Nivolumab in Advanced Melanoma

    Nov 1, 2015, 00:00

  • Companion Devices- Potential Routes To Market

    Nov 1, 2015, 00:00

  • New Drugs In Non-Small Cell Lung Cancer- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

    Nov 1, 2015, 00:00

  • Telemedicine Consultation In The Differential Diagnosis Simple Contact Dermatitis Due To Incontinence And Pressure Sores In Immobilized Patients With Urinary Incontinence - Clinical And Economic Analysis

    Nov 1, 2015, 00:00

  • Nice Medical Technologies Evaluation Programme – Influence Of The Review On Uptake By Procurement Managers And Key Stakeholders

    Nov 1, 2015, 00:00

  • Cyclosporine Is Not The Drug Of Choice For Renal Transplanted Patients And Increases The Risk Of Cardiovascular And Cerebrovascular Accidents

    Nov 1, 2015, 00:00

  • Characteristics Associated With Annual Bleeding Frequency Among Hemophilia Patients In The United States

    Nov 1, 2015, 00:00

  • Years of Working Life Lost Caused By Rheumatic Diseases In Portugal

    Nov 1, 2015, 00:00

  • Avoiding Overestimation In Annualization of Event Risk from Risk Functions for use in Economic Modeling

    Nov 1, 2015, 00:00

  • The Need to Revise Discount Rates in Belgium, The Netherlands, Poland and the Uk

    Nov 1, 2015, 00:00

  • Characteristics of Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States

    Nov 1, 2015, 00:00

  • Prevalence of Antidepressants Prescribed to Tramadol Users In The Uk Primary Care Setting - A Prescription Sequence Symmetry Analysis

    Nov 1, 2015, 00:00

  • Impact of Essential Health Benefit Benchmark Plans on Us Market Access

    Nov 1, 2015, 00:00

  • Healthcare Access Differences between Public and Private Insurance Coverage Among Patients with Depression in Brazil

    Nov 1, 2015, 00:00

  • The Burden of Illness of Congenital Adrenal Hyperplasia In The United Kingdom- A Retrospective, Observational Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Ferric Carboxymaltose In Patients With Iron Deficiency And Chronic Heart Failure In Austria

    Nov 1, 2015, 00:00

  • Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Estimation Of Health Benefits Associated To Early Diagnosis And Treatment Of Copd

    Nov 1, 2015, 00:00

  • Use Of Xanthines In The Treatment Of Chronic Respiratory Diseases In Serbia, Compared With The Scandinavian Countries From 2004 To 2013

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Inflammatory Bowel Disease In Poland (Application of The Eq-5d And Self-Assessment of Health State)

    Nov 1, 2015, 00:00

  • Practical Considerations in the Application of Statistical Methods for Treatment Switching

    Nov 1, 2015, 00:00

  • The Drivers of Facility-Based Immunization Performance and Costs. An Application to Moldova

    Nov 1, 2015, 00:00

  • Access To Innovation And Economic Burden----A Case Of Non-Small Cell Lung Cancer In A Patient Access Program In Qingdao, China

    Nov 1, 2015, 00:00

  • Does Health-Related Quality of Life Evaluation In Psoriasis Matter? A Review of Labels of Psoriasis Products Approved By The Fda and The Ema

    Nov 1, 2015, 00:00

  • Value-Based Pricing Scheme for new Technology in Consideration of Cost-Effectiveness Dominance to the Control

    Nov 1, 2015, 00:00

  • Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Glybera for The Treatment of Lipoprotein Lipase Deficiency

    Nov 1, 2015, 00:00

  • Socioeconomic Impact of Immunoglobulin Replacement Therapy for Primary Immunodeficiency Patients on the Health Public System in Brazil- A Single Center Study

    Nov 1, 2015, 00:00

  • Patients’ Priorities For Treatment In Severe Asthma

    Nov 1, 2015, 00:00

  • Validation of A New Hemophilia-Specific Burden Scale for Caregivers of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)

    Nov 1, 2015, 00:00

  • Description of Baseline Characteristics of Patients Provided Cancer Care within a Novel Commercial Health Plan Cancer Care Quality Program in the First Year

    Nov 1, 2015, 00:00

  • Economic Evaluations Of Glioblastoma

    Nov 1, 2015, 00:00

  • Mapping Health State Utility Values From Eortc Data Collected From A Clinical Trial Population With Relapsed/Refractory Multiple Myeloma

    Nov 1, 2015, 00:00

  • Nationwide Trend Analysis of Targeted Therapies for Treatment Of Malignant Neoplasms of The Eye In Taiwan (2009-2016)

    Nov 1, 2015, 00:00

  • Efficacy And Safety of Surgical Treatment Options for Primary Angle Closure Glaucoma- a Meta-Analysis of Randomised Controlled Trials

    Nov 1, 2015, 00:00

  • National Survey of Behavior, Attitudes and Practice of General Practitioners and Various Specialists Concerning Antimicrobial Use And Resistance in Respiratory Tract Infections

    Nov 1, 2015, 00:00

  • Direct Treatment Costs Of Stroke In Turkey

    Nov 1, 2015, 00:00

  • Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis

    Nov 1, 2015, 00:00

  • The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland- A Comparison Between the use of Denosumab and Zoledronic acid in Patients With Breast Cancer and Bone Met ...

    Nov 1, 2015, 00:00

  • Japanese Population Norms for Preference-Based Measures- Eq-5d-3l, Eq-5d-5l, And Sf-6d

    Nov 1, 2015, 00:00

  • Burden of Metastatic Renal Cell Carcinoma in France From 2008 To 2013- Analysis of the French National Hospital Database

    Nov 1, 2015, 00:00

  • Review of Patient Reported Outcomes In Glaucoma

    Nov 1, 2015, 00:00

  • Assessing Outcomes for Cost-Utility Analyses in Mental Health Interventions- Comparison of Multi-Attribute Utility Instrument Eq-5d with Mental Health Specific Outcomes Ghq12

    Nov 1, 2015, 00:00

  • The German Amnog Drug Reimbursement Process- Factors Associated With Gba-Decisions About The Additional Benefit

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dulaglutide 1.5mg Once Weekly for the Treatment of Patients with Type Two Diabetes Mellitus in Sweden

    Nov 1, 2015, 00:00

  • Design Of Three New Condition-Specific Questionnaires To Assess Quality Of Life, Symptoms And Treatment Satisfaction Of Patients With Abdominal Aortic Aneurysm- The Aneurysm-Dqol, Aneurysm-Srq And Aneurysm-Tsq

    Nov 1, 2015, 00:00

  • Social Demographic Characteristics and Direct Medical Costs For Patients With Parkinson’s Disease In Korea - Big Data Analysis From The National Health Insurance Claims Dataset

    Nov 1, 2015, 00:00

  • Causas Y Factores Asociados Al Delirium En Pacientes Mayores De 65 Años Que Solicitan Atención Médica De Urgencias

    Nov 1, 2015, 00:00

  • Patient Profile of New Users of Novel Oral Anticoagulants in non-Valvular Atrial Fibrillation (Nvaf)- Real-World Evidence from Primary Care Data in Germany

    Nov 1, 2015, 00:00

  • Increased Usage of Calcium Free Balanced Solutions (Bal) in Lieu of 0,9% Saline in Patients Meeting Sirs (Systemic Inflammatory Response Syndrome) Criteria- a Private Brazilian Hospital Perspective

    Nov 1, 2015, 00:00

  • The Budget Impact Of Duoresp® Spiromax® Compared With Commonly Prescribed Dry Powder Inhalers For The Management Of Asthma And Chronic Obstructive Pulmonary Disease In Italy- Estimated Impact Of Inhalation Technique

    Nov 1, 2015, 00:00

  • Do We Need to Strengthen Study Design in Observational Studies?

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis In The Italian Setting

    Nov 1, 2015, 00:00

  • Heterogeneity in Relative Efficacy Assessments (Rea) across European Hta Bodies- Opportunity for Improving Efficiency and Speed of Access to Patients?

    Nov 1, 2015, 00:00

  • Challenges In Economic Evaluation of Antibiotics In Health-Care Acquired Infections- A Targeted Review

    Nov 1, 2015, 00:00

  • Ambulatory Medicines Cost With Transthyretin Familial Amyloid Polyneuropathy In Portugal

    Nov 1, 2015, 00:00

  • Dispensing of The Combination of Amoxicillin With Clavulanic Acid to Elderly Patients- A Database Analysis

    Nov 1, 2015, 00:00

  • Health Outcomes Evaluation Of New Technologies In Clinical Practi The Case Of The Minimally Invasive Insertable Cardiac Monitor

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life, Work Productivity, and Daily Activity Among A Sample of Commercially Insured Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation In The United States

    Nov 1, 2015, 00:00

  • Value Of Implementation Of Physical Exercise For Cancer Survivors

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Secukinumab Compared to Ustekinumab In Patients With Psoriasis From A Swedish Health Care Perspective

    Nov 1, 2015, 00:00

  • Determinantes Socioeconómicos De La Nutrición Infantil En Colombia

    Nov 1, 2015, 00:00

  • Methodological Gaps in the Assessment of the Utility and Burden of Risk Minimisation Interventions

    Nov 1, 2015, 00:00

  • Recurrent Laryngeal Carcinoma Pet Study (Relaps)- Cost Analysis Of 18f-Fdg Pet In Patients With Suspected Recurrent Laryngeal Cancer Previously Treated With Radiotherapy

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Opioid Substitution Treatment in Slovenia

    Nov 1, 2015, 00:00

  • Estimating the additional indirect cost savings of a procalciton-algorithm in adult icu patients with sepsis, as achieved through reduction in antibiotic resistance and c. Difficile infections

    Nov 1, 2015, 00:00

  • Health and Economic Burden of Breast Cancer Mortality in Younger Women Aged 18-44 Years in the United States, 1970-2012

    Nov 1, 2015, 00:00

  • Steps Towards Introducing a System of Health Technologies Assessment in Ukraine

    Nov 1, 2015, 00:00

  • Assessing Japan’s Three Early Access Programs Based On Recent Discussions- Scope And Financial Aid

    Nov 1, 2015, 00:00

  • Impact of Negative Symptoms on Quality of Life in Patients with Schizophrenia

    Nov 1, 2015, 00:00

  • Faster Drug Market Access In Italy- is Class C-Nn The Answer?

    Nov 1, 2015, 00:00

  • Trends and Correlates of Pulmonary Embolism in Hospitalized Spanish Patients

    Nov 1, 2015, 00:00

  • Evaluaci”N De La Prescripci”N Medica De Antihipertensivos En Los Médicos Cardi”Logos Del Hospital Nacional Edgardo Rebagliati Martins, Lima (Peru)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China

    Nov 1, 2015, 00:00

  • Biologic Treatments for Moderate to Severe Naïve Psoriatic Patients- A Budget Impact Analysis In Italy

    Nov 1, 2015, 00:00

  • Federal Purchases of Imatinib Mesylate, Trastuzumab and L-Asparaginase in Brazil, 2004-2013

    Nov 1, 2015, 00:00

  • Análisis de Costo-Efectividad de Inyeccion Intravitrea de Ranibizumab Versus Aflibercept en el Tratamiento de la Perdida Visual Secundaria a Edema Macular Diabetico Desde la Perspectiva del Sistema de Salud en Colombia

    Nov 1, 2015, 00:00

  • A Cost-Utility Analysis of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus and Ciclosporin In Liver Transplant Recipients In The Uk

    Nov 1, 2015, 00:00

  • A Cost Utility Analysis Of Cetuximab For 1st-Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer- A Summary Of The Submission To All Wales Medicines Strategy Group (Awmsg)

    Nov 1, 2015, 00:00

  • Public Health And Economic Impact of A Quadrivalent Influenza Vaccine In Comparison to The Trivalent Influenza Vaccine In Brazil Over The Period Of 2010 – 2013

    Nov 1, 2015, 00:00

  • Willingness to Pay for Quality-Adjusted Life Years In Patients With Diabete

    Nov 1, 2015, 00:00

  • Costo-Efectividad De La Vacuna Contra El Dengue 2014

    Nov 1, 2015, 00:00

  • Comparison of Chronic Hepatitis C Treatment Efficacy in Randomized Controlled Trials and Real-Life Studies - Influence of Study Design in the Sustained Virological Response- A Systematic Review of Published Literature

    Nov 1, 2015, 00:00

  • Health Technology Assessment Archetype- Implication on Launch Planning and Evidence Synthesis

    Nov 1, 2015, 00:00

  • Is Edoxaban Cost-Effective For Non-Valvular Atrial Fibrillation Patients Treated With Vitamin K Antagonists In Spain?

    Nov 1, 2015, 00:00

  • Clinical Effectiveness of Bisphosphonates for Prevention of Fragility Fractures- A Systematic Review and Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Cost-Benefit Analysis Of Yindanxintai Dropping Pills In The Treatment Of Angina Pectoris Caused By Coronary Heart Disease

    Nov 1, 2015, 00:00

  • Markov Modeling of Hiv Infection In Russian Population

    Nov 1, 2015, 00:00

  • Comparison of Bazedoxifene/Conjugated Oestrogens Vs Current Therapies in the Treatment of Postmenopausal Symptoms- Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • A hepatite c crônica diminui a qualidade de vida?

    Nov 1, 2015, 00:00

  • Extracting And Using Data From Electronic Medical Records (Emr) To Monitor Quality Of Care And Prescription Patterns For Diabetes Prevention And Control In Outpatient Clinics Of Low And Mid Resources Countries- The Case Of Colima, Mexico

    Nov 1, 2015, 00:00

  • Predicting Post-Amnog Rebate Outcomes for Oncology Drugs

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Simeprevir and Sofosbuvir Combination Therapy for the Treatment of Genotype 1 Hcv Patients in the Dominican Republic

    Nov 1, 2015, 00:00

  • A Comparison Of Key Components Of The Hta Core Model And The Amcp Format

    Nov 1, 2015, 00:00

  • Costo En Salud En La Intervencion De Prevencion Y Control De Cáncer En El Instituto Nacional De Enfermedades Neoplásicas, 2010-2014

    Nov 1, 2015, 00:00

  • Occurrence of Treatment Interruption During Therapy with Biological Agents in Patients with Previous Anti-Tnf Failure in Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • A Framework for Prioritizing Research Investments in Precision Medicine

    Nov 1, 2015, 00:00

  • Factors Associated with Inadequate Pain Relief in Patients with Primary Knee Osteoarthritis in Portugal- An Analysis from the Survey of Osteoarthritis Real World Therapies (Sort)

    Nov 1, 2015, 00:00

  • Sugammadex- The Right Option for the Efficiency of the Operating Room? A Methodology for Cost / Benefit Analysis in Comparison to the Routine Choice for Reversal

    Nov 1, 2015, 00:00

  • A Comparison of Time to Launch and Reimbursement for New Medicines across Developed Countries

    Nov 1, 2015, 00:00

  • Effectiveness Of The St2 For Prognosis In Heart Failure- Systematic Reviews

    Nov 1, 2015, 00:00

  • Managing Patients With Statin-Associated Symptoms- Does Real-World Clinical Practice Align With Clinical Guidelines And Hta Recommendations In Europe?

    Nov 1, 2015, 00:00

  • Preferences for Dry Powder Inhaler Attributes Among Patients With Asthma and Chronic Obstructive Pulmonary Disease From Five European Countries

    Nov 1, 2015, 00:00

  • Methodology of International Comparison of Pharmaceutical Prices

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Pen Devices For Nph Insulin Administration Compared With Syringe And Vial In Adult Patients With Diabetes Mellitus In Colombia

    Nov 1, 2015, 00:00

  • Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy- The Liguria Region Simulation

    Nov 1, 2015, 00:00

  • Blood Glucose Test Result From Employees At Health Clinic of Songino Khairkhan District

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Model Evaluating Component-Resolved Diagnosis (Crd) Versus Standard Testing Method (Skin Prick Testing (Spt)) In The Diagnosis And Treatment of Allergic Rhinitis In The Netherlands

    Nov 1, 2015, 00:00

  • Health Care Resource use and Costs Among Polycythemia Vera Patients in the United States- Results from an Observational Cohort Study

    Nov 1, 2015, 00:00

  • Does Attrition In Subject-Based Studies Of Drug Safety Lead To Bias Related To Morbidity?

    Nov 1, 2015, 00:00

  • Indirect Comparisons in Benefit Assessment

    Nov 1, 2015, 00:00

  • New Possibility for Testing The Dynamic Stability of The Trunk and Lower Extremities

    Nov 1, 2015, 00:00

  • Assessment of Real-World Treatment Patterns and Outcomes In Relapsed or Refractory Multiple Myeloma- Evidence From A Brief Multi-Country Survey of European Physicians

    Nov 1, 2015, 00:00

  • Analisis del impacto economico de la adopcion de una tecnica minimamente invasiva para la reparacion de hernia ventral. Perspectivas de 4 paises de latinamerica

    Nov 1, 2015, 00:00

  • Economic Burden of Controlled Gout, Uncontrolled Gout, and Gout Exacerbated By Common Comorbidities- Results From The 2012-2013 National Health and Wellness Survey

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Treatment For Chronic Heart Failure- A Systematic Review

    Nov 1, 2015, 00:00

  • Costos de Hospitalización Por Infección Respiratoria Aguda Grave (Irag) en Guatemala

    Nov 1, 2015, 00:00

  • Morbidades E Custos Das Internaçoes Hospitalares Do Sistema Único De Saúde Para Doenças Crônicas Em Maringá, Paraná, Brasil

    Nov 1, 2015, 00:00

  • Budget Impact of Perampanel for The Treatment of Patients With Partial-Onset Seizures (Pos) In Russia

    Nov 1, 2015, 00:00

  • Preferences for Using Phone Calls, Text Messaging, and Email to Communicate with Physicians Among Patients with four chronic diseases

    Nov 1, 2015, 00:00

  • Increasing Precision of Real-World Data Estimates- The Importance of A Step-Wise Process to Limit Data Collection Errors And Data Incompleteness

    Nov 1, 2015, 00:00

  • Economic Evaluation of Targeted Antifungal Treatment Sequencing Strategies For Invasive Aspergillosis Based on Real World Data- The Case of Dutch Clinical Practice

    Nov 1, 2015, 00:00

  • Healthcare Use and Expenditure for Diabetes In Bangladesh- A Matched-Case-Control Study

    Nov 1, 2015, 00:00

  • Mobile Phone Use And Willingness To Pay For Sms For Diabetes In Bangladesh

    Nov 1, 2015, 00:00

  • Experiences of Italian Patients With Diabetes- An Analysis of The Eu Roper Diabetes Study

    Nov 1, 2015, 00:00

  • Incidence of Cardiovascular Events Following Myocardial Infarction in Fran an Observational Analysis Using a Claims Database

    Nov 1, 2015, 00:00

  • Opportunities with Accelerated Approval Times, but Stumbles at Hta? the Impact of a Limited Evidence Package

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of The Use of Daclatasvir for the Treatment of Hepatitis C Virus (Hcv) Genotypes 3 in Cirrhotic Patients Within the Italian National Health Service

    Nov 1, 2015, 00:00

  • Costos de Medicamentos en el Marco de un Programa Presupuestal Para el Vih/Sida en Perú, 2012-2014

    Nov 1, 2015, 00:00

  • Quantifying The Cost And Quality Of Life Implications Of Adverse Events Associated With Long-Term Oral Corticosteroid Use

    Nov 1, 2015, 00:00

  • Are Vaccinations Really Different to Pharmaceuticals With Respect to Market Access In Germany?

    Nov 1, 2015, 00:00

  • Determinantes y Barreras Socioeconómicas del Acceso A Los Servicios de Salud en Las Regiones de Colombia

    Nov 1, 2015, 00:00

  • Cost-Benefit Analysis of Whole Body Bone Scintilography in the Pre-Trasnplant Assesment of Adult Patients Beares of Hepatocellular Carcinoma in a Liver Tranaplant List in the South of Brazil

    Nov 1, 2015, 00:00

  • Integrated Clinical Pathway in Schizophrenia

    Nov 1, 2015, 00:00

  • Epidemiology of Patients Affected by Acute Coronary Syndrome (Acs) Treated with Statins for Hypercholesterolemia from Italian Administrative Official Databases

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Cerebrolysin In The Treatment of Acute Ischemic Stroke of Moderate and Severe Degrees of Severity In The Russian Federation

    Nov 1, 2015, 00:00

  • ANALYSIS OF Hiv – Infection in Kazakhstan

    Nov 1, 2015, 00:00

  • Co-Administration of Proton Pump Inhibitors in Chronic Aspirin Users and the Risk of Adverse Cardiovascular Events- a Population-Based Cohort Study

    Nov 1, 2015, 00:00

  • Mortality Rate and Premature Mortality Due to Systemic Erythematosus Lupus (Sle) in Latin America, Us and England and Wales

    Nov 1, 2015, 00:00

  • Exploring Attitudes and Perceptions of Patients and Staff Towards a Fee For Service “After Hours” Clinic Supplementing Free Hiv Services in Uganda- A Qualitative Study

    Nov 1, 2015, 00:00

  • Burden of Dyslipidaemia in Patients at High Risk for Cardiovascular (Cv) Events- Results of a Canadian Study

    Nov 1, 2015, 00:00

  • Quality of Care For Patients With Diabetes Mellitus (Dm) In Canada- Findings From A National Population-Based Survey

    Nov 1, 2015, 00:00

  • Identifying Research Gaps in Antimicrobial Resistance (Amr)- Literature Review, Potential Research Questions and Study Designs

    Nov 1, 2015, 00:00

  • Health Technology Assessment Practices In Turkey

    Nov 1, 2015, 00:00

  • O Método Paraconsistente Como Suporte Às Tomadas De Decisão Em Saúde

    Nov 1, 2015, 00:00

  • Use of Incremental Cost-Effectiveness Ratio (Icer) in Recommending Technologies Incorporation in the Brazilian Public Health System (Sus), 2012-2015

    Nov 1, 2015, 00:00

  • Exhaled Nitric Oxide For The Diagnosis Of Asthma In Adults And Children- A Systematic Review

    Nov 1, 2015, 00:00

  • How Do we Estimate Quality Adjusted Life Years (Qalys) in Rare Diseases? A Case Study in Hypophosphatasia

    Nov 1, 2015, 00:00

  • Grand-4- The German Retrospective Analysis on Persistence in Women with Osteoporosis Treated with Bisphosphonates or Denosumab

    Nov 1, 2015, 00:00

  • Translation into Russian and Validation of the Cochrane Questionnarie to Assess Risks of Systematic Biases in Randomized Controlled Trials

    Nov 1, 2015, 00:00

  • Cancer Is Associated With Intraoperative And Postprocedural Complications And Disorders

    Nov 1, 2015, 00:00

  • Methotdological Difficulties Of Compliance Analyses Based On Real-World Data

    Nov 1, 2015, 00:00

  • Excess Costs Associated With Possible Misdiagnosis of Alzheimer’s Disease Among Patients With Vascular Dementia In Italy

    Nov 1, 2015, 00:00

  • Assessment of Risk Sharing Agreements (Rsas) in Select Global Markets with Specific Focus on Activities Surrounding Immunomodulators

    Nov 1, 2015, 00:00

  • Long-Term Trends In Descriptive Epidemiology Of Malignant Melanoma In The Slovak Republic

    Nov 1, 2015, 00:00

  • Development and Validation of A Patient-Reported Outcome Measure of the Psychological Impact of Submental Fat

    Nov 1, 2015, 00:00

  • Costo-Efectividad De Los Nuevos Anticoagulantes Orales En Pacientes Con Fibrilacion Auricular No Valvular En Colombia

    Nov 1, 2015, 00:00

  • The Cost Burden of Monoclonal Antibody Therapy In An Athens Greece Tertiary Hospital. A Seven Year Cost Comparison Analysis

    Nov 1, 2015, 00:00

  • Economic Burden Of Acute Myocardial Infarction In Vietnam

    Nov 1, 2015, 00:00

  • Changes In The Prices Of Reference Biotechnology Products By The Penetration Of Biosimilars Into The Turkish Pharmaceutical Market

    Nov 1, 2015, 00:00

  • Anchoring Bias in Tto Valuations

    Nov 1, 2015, 00:00

  • Estimation of Indirect (Work-Related Productivity) Costs Associated With Moderate-To-Severe Plaque Psoriasis In Germany

    Nov 1, 2015, 00:00

  • Efeitos da Atenção Farmacêutica nos Resultados em Saúde Dos Pacientes- Revisão Sistemática Com Meta-Análises

    Nov 1, 2015, 00:00

  • The Use Of Real World Evidence To Support Market Access Of Medical Devices – Implications For The German Setting

    Nov 1, 2015, 00:00

  • Physical Functioning and Pain in Chronic Low Back Pain- a Systematic Review of Psychometric Properties of Various Outcomes Measures

    Nov 1, 2015, 00:00

  • O Processo de Contratualização do Hospital Universitário da Ufjf no Contexto do Sus

    Nov 1, 2015, 00:00

  • Implante de Ahmed Versus Implante de Baerveldt- Una Revisión Sistemática y Meta-Análisis

    Nov 1, 2015, 00:00

  • Does A New Pharmacoeconomic Model Is Demanded for Obesity’s Pharmacotherapy Assessment?

    Nov 1, 2015, 00:00

  • Prevalence and Incidence Estimations in German amnog Applications – The Role of Real-World Evidence (RWE)

    Nov 1, 2015, 00:00

  • How Can We Improve The Design Of Patient Preference Research In Oncology? A Case Study In Metastatic Castrate Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Evolution Of Tiotropium Efficacy Vs. Placebo Over Time For The Maintenance Therapy Of Chronic Obstructive Pulmonary Disease- From Investigational Product To Active Reference

    Nov 1, 2015, 00:00

  • Health-Related Quality Of Life In Heart Failure Patients- Health Utilities And Predictive Determinants

    Nov 1, 2015, 00:00

  • Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

    Nov 1, 2015, 00:00

  • Type II Diabetes Complications’ Cost in Estonia

    Nov 1, 2015, 00:00

  • Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Use of Quality of Care (Qoc) Metrics Among Oncologists In the United States (Us)

    Nov 1, 2015, 00:00

  • Early Economic Evaluation of Short-Term Variability of Qt Intervals As A Potential Test for Predicting The Effectiveness of Icd Implantation In Patients With Heart Failure

    Nov 1, 2015, 00:00

  • Evaluación Económica Completa Del Escáner Cervical Avanzado Como Agente Diagnóstico En Pacientes Mexicanas Con Riesgo Asociado A Cáncer De Cérvix Por Vph En México

    Nov 1, 2015, 00:00

  • Patient Utility Estimates In Patients At High Cardiovascular Risk

    Nov 1, 2015, 00:00
  • «
  • 81
  • 82
  • 83
  • 84 (current)
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »